Skip to content

Home treatment for haemophilia patients.

Home treatment in prophylaxis for haemophilia: A quantitative assessment.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON19959
Enrollment
175
Registered
2011-01-10
Start date
2010-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haemophilia, Home treatment, prophylaxis, intravenous infusion, learningprocess.

Interventions

This study comprises a retro- and prospective observational study which is combined with a nursing consultation. The present project will expand the regular nursing consultation with a history, timing

Sponsors

University Medical Centre Utrecht Heidelberglaan 100, PO box 85500 3508 GA Utrecht, the Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All haemophilia or Von Willebrand type III patients or caretakers of children (with or without CVAD) treated with prophylaxis (possible learning for self infusion); 2. Patients who are treated at the van Creveldkliniek Utrecht, Haemophilia Treatment Centre Amsterdam, or Erasmus Medical Centre Rotterdam, in the estimated period from of 3 years.

Exclusion criteria

Exclusion criteria: Patients who are treated on demand.

Design outcomes

Primary

MeasureTime frame
Quantification of the learning process of self infusion and the self infusion procedure, that will serve as a base-line for futher research to improve adherence.

Secondary

MeasureTime frame
1. Time needed to learn to administer prophylaxis; 2. Timing of self infusion; 3. Proportion of infusions taken in the mornings in comparison with the bleeding frequency; 4. Age at which transition takes place.

Contacts

Public ContactL.H. Schrijvers

PO box 85500

L.H.schrijvers-3@umcutrecht.nl+31 (0)88 7551709

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)